Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.
A significant number of cases of post-COVID-19 myocarditis have been reported.
Cardiologists around the world report experiencing harassment and discrimination in the workplace.
Higher rates of smoking, lower rates of lung cancer screening, and more diagnoses of asthma and COPD have been seen in transgender vs cisgender individuals.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
Lipid-lowering therapies are key to the prevention of cardiovascular (CV) events and CV-related mortality.
Mechanistic and outcomes studies are warranted to elucidate the lipid paradox and CVD risk in rheumatoid arthritis (RA).
Changes to restrictions for telemedicine may have important implications for the management of adult and pediatric diabetes during the COVID-19 pandemic.
